Locke Landon W, Myerburg Michael M, Weiner Daniel J, Markovetz Matthew R, Parker Robert S, Muthukrishnan Ashok, Weber Lawrence, Czachowski Michael R, Lacy Ryan T, Pilewski Joseph M, Corcoran Timothy E
Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Pulmonary Medicine, Allergy, and Immunology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Eur Respir J. 2016 May;47(5):1392-401. doi: 10.1183/13993003.01880-2015. Epub 2016 Mar 23.
Airway surface liquid hyperabsorption and mucus accumulation are key elements of cystic fibrosis lung disease that can be assessed in vivo using functional imaging methods. In this study we evaluated experimental factors affecting measurements of mucociliary clearance (MCC) and small-molecule absorption (ABS) and patient factors associated with abnormal absorption and mucus clearance.Our imaging technique utilises two radiopharmaceutical probes delivered by inhalation. Measurement repeatability was assessed in 10 adult cystic fibrosis subjects. Experimental factors were assessed in 29 adult and paediatric cystic fibrosis subjects (51 scans). Patient factors were assessed in a subgroup with optimal aerosol deposition (37 scans; 24 subjects). Paediatric subjects (n=9) underwent initial and 2-year follow-up scans. Control subjects from a previously reported study are included for comparison.High rates of central aerosol deposition influenced measurements of ABS and, to a lesser extent, MCC. Depressed MCC in cystic fibrosis was only detectable in subjects with previous Pseudomonas aeruginosa infection. Cystic fibrosis subjects without P. aeruginosa had similar MCC to control subjects. Cystic fibrosis subjects had consistently higher ABS rates.We conclude that the primary experimental factor affecting MCC/ABS measurements is central deposition percentage. Depressed MCC in cystic fibrosis is associated with P. aeruginosa infection. ABS is consistently increased in cystic fibrosis.
气道表面液体过度吸收和黏液积聚是囊性纤维化肺病的关键要素,可使用功能成像方法在体内进行评估。在本研究中,我们评估了影响黏液纤毛清除率(MCC)和小分子吸收(ABS)测量的实验因素,以及与异常吸收和黏液清除相关的患者因素。我们的成像技术利用两种通过吸入给药的放射性药物探针。在10名成年囊性纤维化受试者中评估了测量的重复性。在29名成年和儿科囊性纤维化受试者(51次扫描)中评估了实验因素。在气溶胶沉积最佳的亚组(37次扫描;24名受试者)中评估了患者因素。儿科受试者(n = 9)接受了初始和2年随访扫描。纳入了先前报道研究中的对照受试者进行比较。中央气溶胶沉积率高会影响ABS的测量,对MCC的影响较小。囊性纤维化患者中MCC降低仅在先前有铜绿假单胞菌感染的受试者中可检测到。没有铜绿假单胞菌感染的囊性纤维化受试者的MCC与对照受试者相似。囊性纤维化受试者的ABS率始终较高。我们得出结论,影响MCC/ABS测量的主要实验因素是中央沉积百分比。囊性纤维化患者中MCC降低与铜绿假单胞菌感染有关。囊性纤维化患者的ABS持续增加。